Análisis de los factores pronósticos en los tumores vesicales superficiales

Archivos Espanoles de Urologia

Volumn 50, Issue 2, 1997, Pages 121-126

  Páez Borda, Álvaro ^a   Martín Osés, Eduardo ^a   De La Cal López, Miguel ^a   Llorente Abarca, Carlos ^a   Berenguer Sánchez, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STATISTICAL MODEL; TUMOR RECURRENCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 0346058077     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BOUFFIOUX, CH ' DENIS, L.' OOSTERLINCK, W. y cols.: "Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European Organization for Research on Treatment of Cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin." J. Urol., 148" 297, 1992.
2. HERR, H. W.: "Transurethral resection and intravesical therapy of superficial bladder tumors." Urol. Clin. North Am., 18: 525, 1991.
3. LAMM, D. L.; BLUMENSTEIN, B. A.; CRAWFORD, E. D. y cols.: "A randomized trial of intravesical doxorubicin and immunotherapy with bacillus Calmette-Guérin for transitional cell carcinoma of the bladder." N. Engl. J. Med., 325: 1.205, 1991.
4. MARTÍNEZ-PIÑEIRO, J. A.; JIMÉNEZ LEÓN, J.; MARTÍNEZ-PIÑEIRO, L. y cols.: "Bacillus Clamette-Guérin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer." J. Urol., 143: 502, 1990.
5. OOSTERLINCK, W.; KURTH, K. H.; SCHRÖDER, F. y cols.: "A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single Ta, T1 papillary carcinoma of the bladder." J. Urol., 149: 749, 1993.
6. RÜBBEN, H.; GRAF-DOBBERSTEIN; OSTWALD, R. y cols.: "Prospective randomized study of adjuvant therapy after complete resection of superficial bladder cancer; mitomycin C vs BFC Connaught vs TUR alone." In: International Society Urology Reports IMMUNOTHERAPY OF UROLOGICAL TUMOURS. Ed. J. B. deKernion. Chapt. 3, Edinburgh, Curchill Livingstone, pp: 27-36, 1990.
7. VEGT, P. D. J.; WITJES, J. A.; WITJES, W. P. J. y cols.: "A randomized study of intravesical mitomycin C, bacillus Calmette-Guèrin TICE and bacillus Calmette-Guèrin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder." J. Urol., 153: 929, 1995.
8. International Union Against Cancer. TNM Atlas. Third Edition. Heidelberg, Springer-Verlag, 1989.
9. MOSTOFI, F. K.; SOBIN, L. H. y TORLINI, H.: "Histological Typing of Urinary Bladder Tumours." International Histological Classification of Tumours #10. Geneva, World Health Organization, 1973.
10. PÁEZ, A.; DE LA CAL, M. A.; LLORENTE, C. y cols.: "Tratamicnto expectante de los tumores vesicales superficiales: resultados preliminares." Act. Urol. Esp., 19: 288, 1995.
11. PROUT, G. R. Jr.; BASSIL, B. y GRIFFIN, P.: "The treated histories of patients with Ta grade 1 transitional-cell carcinoma of the bladder." Arch. Surg., 121: 1.463, 1986.
12. HERR, H. W. y LAUDONE, V. P.: "Intravesical therapy for superficial bladder cancer." In: Cancer: Principles & Practice of Oncology. Eds.: De Vita Jr., V. T., Helliman, S. & Rosenberg, S. A. Vol. 2. Philadelphia, J. B. Lippincott Company, pp. 1-10, 1988.
13. HENEY, N. M.; AHMED, S.; FLANAGAN, M. J. y cols.: "Superficial bladder cancer: progression and recurrence." J. Urol., 130: 1.083, 1983.
14. CIFUENTES DELATTE, L.; GARCÍA DE LA PEÑA, E. Y VELA NAVARRETE, R.: "Survival rates of patients with bladder tumors. An experience of 1.744 cases." Br. J. Urol., 54: 267, 1982.
15. HERR, H. W.; LAUDONE, V. P. Y WHITMORE Jr., W. F.: "An overview of intravesical therapy for superficial bladder tumors." J. Urol., 138: 1.363, 1987.
16. ABEL, P. D.: "Prognostic indices in transitional cell carcinoma of the bladder." Br. J. Urol., 62: 103, 1988.
17. OOMS, E. C. M.; ANDERSON, W. A. D.; ALONS, C. L. y cols.: "Analysis of the performance of pathologists in the grading of bladder tumors." Hum. Path., 14: 140, 1983.
18. ABEL, P. D.; HENDERSON, D.; BENNETT, M. K. y cols.: "Differing interpretations of the pT category and grade of trasitional cell cancer of the bladder by pathologists." Br. J. Urol., 62: 339, 1988.
19. DALESIO, O.; SCHULMAN, C. C.; SILVESTER, R. y cols.: "Prognostic factors in superficial bladder tumors: a study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group." J. Urol., 129: 730, 1983.
20. CHERRIE, R. J.; LINDNER, A. Y DE KERNION, J. B.: "Transitional cell carcinoma of bladder in first four decades of life." Urology, 20: 582, 1982.
21. FITZPATRICK, J. M. Y REDA, M.: "Bladder carcinoma in patients 40 years of less." J. Urol., 135: 53, 1986.
22. BENSON, R. C. (Jr.); TOMERA, K. M. Y KELALIS, P. P.: "Transitional cell carcinoma of the bladder in children and adolescents." J. Urol., 130: 54, 1983.
23. KLEIN, F. A.; HERR, H. W.; SOGANI, P. C. y cols.: "Detection and follow-up of carcinoma of the urinary bladder by flow cytometry." Cancer, 50: 389, 1982.
24. FALOR, W. H. y WARD-SKINNER, R. M.: "The importance of marker chromosomes in superficial transitional cell carcinoma of the bladder: 50 patients followed up to 17 years." J. Urol., 139: 929, 1988.
25. APRIKIAN, A. G.; SARKIS, A. S.; REUTER, V. E. y cols.: "Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts." Sem. Urol., 11: 137, 1993.
26. FRADET, Y.; Y CORDON-CARDO, C.: "Critical appraisal of tumor markers in bladder cancer." Sem. Urol., 11: 145, 1993.